143 related articles for article (PubMed ID: 27912126)
1. Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity.
Colavita F; Quartu S; Lalle E; Bordi L; Lapa D; Meschi S; Vulcano A; Toffoletti A; Bordi E; Paglia MG; Di Caro A; Ippolito G; Capobianchi MR; Castilletti C
J Clin Virol; 2017 Jan; 86():27-30. PubMed ID: 27912126
[TBL] [Abstract][Full Text] [Related]
2. The effect of a non-denaturing detergent and a guanidinium-based inactivation agent on the viability of Ebola virus in mock clinical serum samples.
Burton JE; Easterbrook L; Pitman J; Anderson D; Roddy S; Bailey D; Vipond R; Bruce CB; Roberts AD
J Virol Methods; 2017 Dec; 250():34-40. PubMed ID: 28941617
[TBL] [Abstract][Full Text] [Related]
3. Development and Testing of a Method for Validating Chemical Inactivation of Ebola Virus.
Alfson KJ; Griffiths A
Viruses; 2018 Mar; 10(3):. PubMed ID: 29533988
[TBL] [Abstract][Full Text] [Related]
4. Ebola Virus Inactivation by Detergents Is Annulled in Serum.
van Kampen JJA; Tintu A; Russcher H; Fraaij PLA; Reusken CBEM; Rijken M; van Hellemond JJ; van Genderen PJJ; Koelewijn R; de Jong MD; Haddock E; Fischer RJ; Munster VJ; Koopmans MPG
J Infect Dis; 2017 Oct; 216(7):859-866. PubMed ID: 28961947
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients.
Tempestilli M; Pucci L; Notari S; Di Caro A; Castilletti C; Rivelli MR; Agrati C; Pucillo LP
Clin Chem Lab Med; 2015 Nov; 53(12):1967-73. PubMed ID: 26053010
[TBL] [Abstract][Full Text] [Related]
6. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.
Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH
Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Four Disinfectants against Ebola Virus on Different Materials.
Smither S; Phelps A; Eastaugh L; Ngugi S; O'Brien L; Dutch A; Lever MS
Viruses; 2016 Jul; 8(7):. PubMed ID: 27399759
[TBL] [Abstract][Full Text] [Related]
9. Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus.
Pinsky BA; Sahoo MK; Sandlund J; Kleman M; Kulkarni M; Grufman P; Nygren M; Kwiatkowski R; Baron EJ; Tenover F; Denison B; Higuchi R; Van Atta R; Beer NR; Carrillo AC; Naraghi-Arani P; Mire CE; Ranadheera C; Grolla A; Lagerqvist N; Persing DH
PLoS One; 2015; 10(11):e0142216. PubMed ID: 26562786
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products.
Remington KM; Trejo SR; Buczynski G; Li H; Osheroff WP; Brown JP; Renfrow H; Reynolds R; Pifat DY
Vox Sang; 2004 Jul; 87(1):10-8. PubMed ID: 15260817
[TBL] [Abstract][Full Text] [Related]
11. West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation.
Mather T; Takeda T; Tassello J; Ohagen A; Serebryanik D; Kramer E; Brown F; Tesh R; Alford B; Chapman J; Lazo A
Transfusion; 2003 Aug; 43(8):1029-37. PubMed ID: 12869107
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Blood-Borne Enveloped Viruses with the Nonionic Detergent 2-[4-(2,4,4-Trimethylpentan-2-yl)Phenoxy]Ethanol Does Not Bias Clinical Chemistry Results.
Bailey AL; Farnsworth C
J Appl Lab Med; 2021 Sep; 6(5):1123-1132. PubMed ID: 33993264
[TBL] [Abstract][Full Text] [Related]
13. Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections.
Remy MM; Alfter M; Chiem MN; Barbani MT; Engler OB; Suter-Riniker F
Clin Microbiol Infect; 2019 Jul; 25(7):907.e7-907.e12. PubMed ID: 30391583
[TBL] [Abstract][Full Text] [Related]
14. Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.
Smither SJ; Weller SA; Phelps A; Eastaugh L; Ngugi S; O'Brien LM; Steward J; Lonsdale SG; Lever MS
J Clin Microbiol; 2015 Oct; 53(10):3148-54. PubMed ID: 26179307
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB
PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714
[TBL] [Abstract][Full Text] [Related]
16. Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.
Cap AP; Pidcoke HF; Keil SD; Staples HM; Anantpadma M; Carrion R; Davey RA; Frazer-Abel A; Taylor AL; Gonzales R; Patterson JL; Goodrich RP
Transfusion; 2016 Mar; 56 Suppl 1(Suppl 1):S6-15. PubMed ID: 27001363
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a Triton X-100 replacement for virus inactivation.
Luo W; Hickman D; Keykhosravani M; Wilson J; Fink J; Huang L; Chen D; O'Donnell S
Biotechnol Prog; 2020 Nov; 36(6):e3036. PubMed ID: 32533632
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study on the effects of Triton X-100 for the in vitro inactivation of Ebola virus on haematological assays.
Mifsud A; Peelen D; Brincat P; Abela S; Debattista N; Laspina S; Zammit D; Camilleri DJ; Gatt A
J Clin Pathol; 2016 Jul; 69(7):637-42. PubMed ID: 26670745
[TBL] [Abstract][Full Text] [Related]
19. Effective Chemical Inactivation of Ebola Virus.
Haddock E; Feldmann F; Feldmann H
Emerg Infect Dis; 2016 Jul; 22(7):1292-4. PubMed ID: 27070504
[TBL] [Abstract][Full Text] [Related]
20. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products.
Roberts P
Biologicals; 2000 Mar; 28(1):29-32. PubMed ID: 10799053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
